blog.bioindustry.org
BIA video showcase: Astex and Novartis’ new Kisqali drug
Kisqali was developed by Novartis Institutes for BioMedical Research (NIBR) under a research collaboration with Astex announced in December 2005. Kisqali is a selective CDK inhibitor, a new class o…